The newly updated Pharmaceutical Research and Manufacturers of America's Code on Interactions with Healthcare Professionals, released in July, is much more specific about CME than the original 2002 version. It states that companies should separate their grants offices from sales and marketing departments — something many companies have already done — and stipulates that companies should develop objective criteria for making CME grant decisions.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments